Venous thromboembolism in the Get With The Guidelines-Stroke acute ischemic stroke population: incidence and patterns of prophylaxis.

[1]  M. Tietze,et al.  Deep Vein Thrombosis/Pulmonary Embolism: A Survey of Self‐Reported Prevention Practices Among Hospitals , 2012, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[2]  Eric E. Smith,et al.  Data quality in the American Heart Association Get With The Guidelines-Stroke (GWTG-Stroke): results from a national data validation audit. , 2012, American heart journal.

[3]  Mary Kwasny,et al.  “Tap and Twist”: Preventing Deep Vein Thrombosis in Neuroscience Patients Through Foot and Ankle Range-of-Motion Exercises , 2011, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[4]  F. Wolfe,et al.  The Hawthorne Effect, Sponsored Trials, and the Overestimation of Treatment Effectiveness , 2010, The Journal of Rheumatology.

[5]  S. Goldhaber,et al.  Long-term complications of medical patients with hospitalacquired venous thromboembolism , 2009, Thrombosis and Haemostasis.

[6]  Li Liang,et al.  Get With the Guidelines–Stroke Is Associated With Sustained Improvement in Care for Patients Hospitalized With Acute Stroke or Transient Ischemic Attack , 2009, Circulation.

[7]  G. Maxwell,et al.  Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. , 2009, Cancer control : journal of the Moffitt Cancer Center.

[8]  Adrian Hernandez,et al.  Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. , 2009, American heart journal.

[9]  P. Kamphuisen,et al.  Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury , 2008, Current opinion in critical care.

[10]  J. Douketis,et al.  Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta‐analysis , 2008, Journal of thrombosis and haemostasis : JTH.

[11]  Adnan I. Qureshi,et al.  Guidelines for the Early Management of Adults With Ischemic Stroke , 2007 .

[12]  C. Kase,et al.  The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison , 2007, The Lancet.

[13]  D. D. De Silva,et al.  Deep Vein Thrombosis following Ischemic Stroke among Asians , 2006, Cerebrovascular Diseases.

[14]  P. Braveman,et al.  Health disparities and health equity: concepts and measurement. , 2006, Annual review of public health.

[15]  Wendy Kehl-Pruett.  Deep vein thrombosis in hospitalized patients: a review of evidence-based guidelines for prevention. , 2006, Dimensions of critical care nursing : DCCN.

[16]  R. Glynn,et al.  Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. , 2005, American journal of epidemiology.

[17]  P. Groeneveld,et al.  Technology Diffusion, Hospital Variation, and Racial Disparities Among Elderly Medicare Beneficiaries: 1989–2000 , 2005, Medical care.

[18]  Joanne M Churak.  Racial and ethnic disparities in renal transplantation. , 2005, Journal of the National Medical Association.

[19]  P. Gorelick,et al.  Stroke in black Americans , 2005, Current cardiology reports.

[20]  A. Rudd,et al.  Venous Thromboembolism After Acute Ischemic Stroke: A Prospective Study Using Magnetic Resonance Direct Thrombus Imaging , 2004, Stroke.

[21]  W. Geerts,et al.  Prevention of venous thromboembolism in the ICU. , 2003, Chest.

[22]  M. Monreal,et al.  The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients. , 2003, Journal of vascular surgery.

[23]  M. Kaste,et al.  Enoxaparin vs heparin for prevention of deep‐vein thrombosis in acute ischaemic stroke: a randomized, double‐blind study , 2002, Acta neurologica Scandinavica.

[24]  A. Turpie,et al.  A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. , 1999, The New England journal of medicine.

[25]  Zheng-Ming Chen,et al.  CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.

[26]  Peter Sandercock,et al.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.

[27]  A. Ahuja,et al.  Low-molecular-weight heparin for the treatment of acute ischemic stroke , 1995 .

[28]  P Landau,et al.  Deep vein thrombosis: prevention in stroke patients during rehabilitation. , 1995, Archives of physical medicine and rehabilitation.

[29]  J. Slattery,et al.  Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[30]  P. Sandset,et al.  A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. , 1990, Seminars in thrombosis and hemostasis.

[31]  A. Serradimigni,et al.  Prévention des thromboses veineuses profondes des membres inférieurs par une fraction d'héparine de très bas poids moléculaire (CY 222) chez des patients porteurs d'une hémiplégie secondaire à un infarctus cérébral: étude pilote randomisée (30 patients) , 1990 .

[32]  M. Prins,et al.  Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. , 1989, Haemostasis.

[33]  W. Crowe,et al.  Occult proximal deep vein thrombosis: its prevalence among patients admitted to a rehabilitation hospital. , 1988, Archives of physical medicine and rehabilitation.

[34]  J. Hirsh,et al.  DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE , 1987, The Lancet.

[35]  M. M. Fukujima,et al.  Prevention of Deep Venous Thrombosis and Pulmonary Embolism , 1986, The Lancet.

[36]  S. McCarthy,et al.  Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke. , 1986, Age and ageing.

[37]  C. Hawkey,et al.  LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE , 1977, The Lancet.

[38]  C. Warlow,et al.  Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. , 1976, British medical journal.

[39]  Plumley Pf.  Letter: the consultants' contract. , 1975, Lancet.

[40]  C. Warlow,et al.  Venous thrombosis following strokes. , 1972, Lancet.